INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $364,000 | -6.9% | 89,836 | -3.5% | 0.00% | – |
| Q4 2016 | $391,000 | -43.4% | 93,047 | -8.5% | 0.00% | – |
| Q3 2016 | $691,000 | +17.1% | 101,652 | -0.5% | 0.00% | – |
| Q2 2016 | $590,000 | -3.0% | 102,152 | +17.3% | 0.00% | – |
| Q1 2016 | $608,000 | -3.0% | 87,109 | 0.0% | 0.00% | – |
| Q4 2015 | $627,000 | -44.2% | 87,109 | -33.2% | 0.00% | -100.0% |
| Q3 2015 | $1,124,000 | -19.9% | 130,447 | +50.0% | 0.00% | 0.0% |
| Q2 2015 | $1,404,000 | – | 86,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 624,673 | $481,000 | 0.30% |
| WEDBUSH SECURITIES INC | 98,255 | $76,000 | 0.01% |
| Paulson Wealth Management Inc. | 11,250 | $9,000 | 0.01% |
| Indiana Trust & Investment Management CO | 19,250 | $15,000 | 0.01% |
| HYMAN CHARLES D | 30,000 | $23,000 | 0.00% |
| Baker Brothers Advisors | 331,393 | $255,000 | 0.00% |
| Virtu Financial LLC | 41,079 | $32,000 | 0.00% |
| WELCH & FORBES LLC | 100,393 | $78,000 | 0.00% |
| BOSTON FINANCIAL MANGEMENT LLC | 42,424 | $33,000 | 0.00% |
| Valeo Financial Advisors, LLC | 5,750 | $4,000 | 0.00% |